Nisa Investment Advisors
CODX

Nisa Investment Advisors’s Co-Diagnostics CODX Stock Holding History

Nisa Investment Advisors’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-50
Closed -$8K – 2587
2022
Q2 		$8K Hold
50
– – ﹤0.01% 2214
2022
Q1 		$9K Hold
50
– – ﹤0.01% 2224
2021
Q4 		$11K Hold
50
– – ﹤0.01% 2014
2021
Q3 		$15 Hold
50
– – ﹤0.01% 2146
2021
Q2 		$12 Hold
50
– – ﹤0.01% 2202
2021
Q1 		$14 Buy
50
+17
+52% +$6.79K ﹤0.01% 2168
2020
Q4 		$9K Buy
+33
New +$12.2K ﹤0.01% 2218

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Nisa Investment Advisors's CODX Position: Q3 2022 in Review

Nisa Investment Advisors sold out of Co-Diagnostics (CODX) in Q3 2022, closing a stake of 50 shares — an estimated $8K sold.

Nisa Investment Advisors first reported a position in CODX in Q4 2020 and held it in 7 quarters. The position peaked at $11K in Q4 2021. 65 funds tracked by Wall St. Rank hold CODX as of Q3 2022.

  • Nisa Investment Advisors reported no remaining Co-Diagnostics position as of Q3 2022 after selling out during the quarter.
  • Nisa Investment Advisors sold 50 Co-Diagnostics shares in Q3 2022, an estimated $8K.
  • Nisa Investment Advisors first reported a position in Co-Diagnostics in Q4 2020 and held it in 7 quarters.
  • Nisa Investment Advisors's Co-Diagnostics position peaked at $11K in Q4 2021.
  • 65 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2022.

Based on Nisa Investment Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.